Abstract: The present disclosure is directed to apparatus and method for more efficiently and effectively refining alum process residue into commercially useable compounds. Materials that contain aluminum or aluminum oxide are provided to a vessel where a chemical rection is controlled when a product is made. Materials that include aluminum can be provided to the vessel and acid can also be provided to the vessel to initiate a chemical reaction. Masses of respective materials provided to the vessel can be controlled according to a regimen for making a product. Temperatures of the vessel can be monitored and controlled while the reaction occurs. Activated carbon may be added to the vessel to help the product performance and stability. Once the product is formed, it is output from the vessel and cooled. The product can be subsequently processed using techniques such as grinding and screening when a final product is prepared.

Abstract: A method for treating ascites patients by administering the peptide drug terlipressin by continuous infusion. The patients include those whose ascites condition has not progressed to hepatorenal syndrome (HRS). Administration may be accomplished with a continuous infusion pump.

Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.

Abstract: An adaptable handle and mount provided for the use with tools needing the assist of a handle. Handle is used in a horizontal fashion and offers the user a no grip solution. The handle comprises a palm rest that is intended to be positioned in your palm, having additional features for comfort. The handle also includes a hand strap that is fastened to the palm rest, its function is to secure the handle assembly firmly to the hand. Also consists of a connection point for attaching handle to the tool with a threaded bolt, nut, and push-on bolt retainer used for Anti-rotation and handle to tool alignment. Further comprised of a mount consisting of an aluminum block with female threads sized and shaped to allow for sufficient adhesion of a high bond, double sided, acrylic adhesive tape to accommodate original tools design.

Abstract: A method for accurately administering a substance to a subject in motion is provided including obtaining one or more scans of the subject. The subject has at least one defined target region thereon for delivery of the substance. A three dimensional position of the subject in motion is calculated based on the obtained one or more scans of the subject. The three dimensional position includes X, Y, and Z coordinates defining the three dimensional position. A timing adjustment is calculated based on the calculated three dimensional position of the subject in motion. A timing of the delivery of the substance to the at least one defined target region is adjusted based on the subject using the calculated timing adjustment. The obtaining, calculating the three dimensional position, calculating the timing adjustment and the adjusting are performed by at least one processor.

Abstract: Provided herein are techniques for enabling communications between an access point (AP) and a number of stations (STAs) while maximizing transmission quality and/or minimizing power consumption. For example, an STA may be associated with a camera device used to capture video data and transmit the video data to the AP, and the AP may be configured to receive a registration request from the STA, register the STA, receive video data from the STA, and transmit the video data to a backend system such as a storage server. In some cases, the AP and STAs may communicate using a communication bandwidth that is sub-GHz but has a higher bandwidth relative to the low-bandwidth sub-GHz communication protocols discussed above. An example of such a high-bandwidth sub-GHz communication protocol is one that supports data transmission (e.g., video data transmission) using a bandwidth of 900 megahertz (MHz).

Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.

Abstract: A method for treating ascites patients by administering the peptide drug terlipressin by continuous infusion. The patients include those whose ascites condition has not progressed to hepatorenal syndrome (HRS). Administration may be accomplished with a continuous infusion pump.

Abstract: A magnetic holder that can be adapted to any flat surface metal or plastic providing magnetic holding of Ferrous objects. Having a waterproof assembly that is washable in cold/hot water. The holder comprises of two neodymium epoxy coated magnets with appropriate size achieving proper hold. Also consisting of proper spacing between the two magnets minimizing movement of objects being held. Further consisting of high bond, double sided foam acrylic adhesive tape to attach magnets to surfaces needing a holder. Currently being used with the Drywall Hawk and Mud Pan.

Abstract: A method for treating ascites patients by administering the peptide drug terlipressin by continuous infusion. The patients include those whose ascites condition has not progressed to hepatorenal syndrome (HRS). Administration may be accomplished with a continuous infusion pump.

Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.

Abstract: A centrifugal pendulum absorber, including: a first pendulum mass; a second pendulum mass; a center plate axially located between the first pendulum mass and the second pendulum mass, connected to the first pendulum mass and the second pendulum mass, and arranged to receive rotational torque; a first resilient bumper axially located between the first pendulum mass and the second pendulum mass, and connected to the first pendulum mass and the second pendulum mass; and a first radial travel stop connected to the first pendulum mass or to the second pendulum mass, located radially outward of the first resilient bumper, radially aligned with at least a portion of the first resilient bumper, and free of contact with the first resilient bumper when the centrifugal pendulum absorber is at rest.

Abstract: The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.

Abstract: A method for treating ascites patients by administering the peptide drug terlipressin by continuous infusion. The patients include those whose ascites condition has not progressed to hepatorenal syndrome (HRS). Administration may be accomplished with a continuous infusion pump.

Abstract: A torque converter comprises a front cover, an impeller having an impeller shell fixed to the front cover, and a turbine fluidly coupled with the impeller and having a turbine shell. A damper assembly is provided that includes an output flange connected to the turbine shell. A clutch assembly is disposed between the front cover and the turbine. The clutch assembly comprises a piston sealed to the front cover at an outer diameter thereof and a clutch flow deflector plate disposed axially between the piston and the output flange, wherein the clutch flow deflector plate is configured to direct a cooling fluid to the clutch assembly.

Abstract: A centrifugal pendulum absorber, including: a first pendulum mass; a second pendulum mass; a center plate axially located between the first pendulum mass and the second pendulum mass, connected to the first pendulum mass and the second pendulum mass, and arranged to receive rotational torque; a first resilient bumper axially located between the first pendulum mass and the second pendulum mass, and connected to the first pendulum mass and the second pendulum mass; and a first radial travel stop connected to the first pendulum mass or to the second pendulum mass, located radially outward of the first resilient bumper, radially aligned with at least a portion of the first resilient bumper, and free of contact with the first resilient bumper when the centrifugal pendulum absorber is at rest.

Abstract: The use of direct factor Xa inhibitors, administered in a dose sufficient to reduce the activity of factor Xa to about 25% less than normal or lower, has the effect of preventing the onset of atherosclerosis, and stabilizing atherosclerotic lesions, and preventing the occurrence or recurrence of atherosclerotic events.

Abstract: The use of direct factor Xa inhibitors, administered in a dose sufficient to reduce the activity of factor Xa to about 25% less than normal or lower, has the effect of preventing the onset of atherosclerosis, and stabilizing atherosclerotic lesions, and preventing the occurrence or recurrence of atherosclerotic events.

Abstract: A hybrid drive system includes a dual mass flywheel having an input side adapted for connection to a crankshaft of an internal combustion engine and an output. A dry damper assembly having an input flange is connected to an output of the dual mass flywheel and an output flange. An electric motor having a fixed mounted stator and a rotor is provided, and the output flange is connected to the rotor. A torque converter having a torque converter input is connected to the rotor and a torque converter output flange is adapted for connection to a downstream drive input shaft.